Toronto Dominion Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-82,200
Closed -$11.6M 1506
2019
Q2
$11.6M Buy
+82,200
New +$22.5M 0.02% 434
2019
Q1
Sell
-700
Closed -$184K 1594
2018
Q4
$184K Sell
700
-29,300
-98% -$8.06M ﹤0.01% 1108
2018
Q3
$8.22M Buy
+30,000
New +$7.79M 0.02% 536
2018
Q2
Sell
-12,500
Closed -$2.75M 1472
2018
Q1
$2.75M Buy
+12,500
New +$2.94M 0.01% 730

Other funds holding ELV

Toronto Dominion Bank's ELV Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Elevance Health (ELV) stake by 8.9% in Q1 2026, selling an estimated $2.54M and leaving 79,034 shares worth $23.1M. The position accounts for 0.03% of the portfolio, ranked #396.

Toronto Dominion Bank first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $187M in Q2 2021. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Toronto Dominion Bank held 79,034 shares of Elevance Health worth $23.1M as of Q1 2026.
  • Toronto Dominion Bank sold 7,715 Elevance Health shares in Q1 2026, an estimated $2.54M.
  • Elevance Health made up 0.03% of Toronto Dominion Bank's portfolio in Q1 2026, its #396 holding.
  • Toronto Dominion Bank first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Elevance Health position peaked at $187M in Q2 2021.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.